Loading...

Financial Statements

Applied DNA Sciences Inc

Applied DNA Sciences Inc (APDN)

Industrials

Income Statement

Download APDN income statement Download APDN income statement
Year 2009201020112012201320142015201620172018
Revenue 0.300.520.971.852.042.729.014.194.753.90
Cost of Revenue 0.06-----0.381.171.081.21
Gross Profit 0.230.520.971.852.042.728.623.023.672.70
R&D Expenses 0.140.080.270.430.691.302.583.702.282.75
Sales, General and Administrative Expense 6.587.198.397.6211.2013.2513.4110.8113.3211.04
Operating Expenses 7.137.649.038.3612.2114.9916.4815.2216.4914.34
Operating Income -6.90-7.12-8.06-6.51-10.18-12.27-7.85-12.20-12.82-11.65
Interest Expense 1.180.792.460.64-0.000.010.02-0.01-0.000.01
Earnings before Tax 3.95-7.91-10.52-7.15-17.69-13.07-11.88-12.18-12.86-11.69
Income Tax Expense 0.00---------
Net Income 3.94-7.91-10.52-7.15-17.69-13.07-11.88-12.18-12.86-11.69
Net Income - Non-Controlling int ----------
Net Income - Discounted ops ----------
Net Income Com 3.94-7.91-10.52-7.15-17.69-13.07-11.88-12.18-12.86-11.69
Preferred Dividends ----------
Earnings Per Share Basic 1.20-1.80-1.80-0.74-1.51-0.97-0.63-0.51-0.49-0.40
Earnings Per Share Diluted 1.20-1.80-1.80-0.74-1.51-0.97-0.63-0.51-0.49-0.40
Weighted Average Shares Outstanding 4.195.016.289.6011.7313.5218.9423.6926.3829.50
Weighted Average Shares Outstanding (Diluted) 5.155.016.289.6011.7313.5218.9423.6926.3829.50
Dividend per Share ----------
Gross Margin 0.791.001.001.001.001.000.960.720.770.69
EBITDA Margin 18.79-12.97-7.94-3.34-8.59-4.63-1.26-2.74-2.57-2.85
EBIT Margin 17.37-13.69-8.32-3.51-8.69-4.80-1.32-2.91-2.71-2.99
Profit Margin 13.36-15.21-10.85-3.85-8.69-4.80-1.32-2.91-2.71-3.00
Free Cash Flow margin -0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
EBITDA 5.55-6.75-7.69-6.19-17.48-12.61-11.37-11.48-12.23-11.14
EBIT 5.13-7.12-8.06-6.51-17.69-13.06-11.86-12.19-12.86-11.68
Consolidated Income 3.94-7.91-10.52-7.15-17.69-13.07-11.88-12.18-12.86-11.69
Earnings Before Tax Margin 13.37-15.22-10.85-3.86-8.69-4.80-1.32-2.91-2.71-3.00
Net Profit Margin 13.36-15.22-10.85-3.86-8.69-4.80-1.32-2.91-2.71-3.00

Balance Sheet Statement

Download APDN income statement Download APDN income statement
Year 2009201020112012201320142015201620172018
Cash and cash equivalents 0.220.032.770.766.411.457.384.543.021.72
Short-term investments ----------
Cash and short-term investments 0.220.032.770.766.411.457.384.543.021.72
Receivables 0.050.060.210.300.670.835.437.912.591.49
Inventories -------0.300.330.22
Property, Plant & Equipment Net 0.010.000.090.210.700.580.570.790.520.42
Goodwill and Intangible Assets 1.000.640.27-0.420.331.881.811.331.15
Long-term investments ----------
Tax assets ----------
Total non-current assets -0.22--2.641.100.321.12-2.06
Total current assets 1.171.170.470.251.171.144.024.211.911.63
Total assets 1.511.413.501.358.373.5115.5515.578.155.63
Payables 0.840.970.770.590.971.492.712.460.940.97
Short-term debt 2.411.823.73--1.80----
Total current liabilities 3.252.794.500.591.123.882.674.081.302.82
Long-term debt -0.22-------1.59
Total debt 2.412.043.73--1.80---1.59
Deferred revenue ----0.150.580.282.740.351.86
Tax Liabilities ----------
Deposit Liabilities ----------
Total non-current liabilities -0.22--2.641.100.321.12-2.06
Total liabilities 3.253.014.500.593.764.972.995.201.304.88
Other comprehensive income ----------
Retained earnings (deficit) -143.43-151.34-161.86-169.01-186.69-199.76-211.64-223.82-236.67-248.37
Total shareholders equity -1.75-1.60-1.000.764.62-1.4712.5710.376.860.75
Investments ----------
Net Debt 2.192.020.96-0.76-6.410.35-7.38-4.54-3.02-0.14
Other Assets 0.070.150.050.040.120.08-1.27-1.400.310.57
Other Liabilities ----0.150.58-0.041.620.351.86

Cash Flow Statement

Download APDN income statement Download APDN income statement
Year 2009201020112012201320142015201620172018
Depreciation & Amortization 0.420.370.370.310.210.440.490.710.630.55
Stock-based compensation 3.393.802.931.951.522.034.022.043.261.36
Operating Cash Flow -2.47-2.46-3.76-3.96-7.87-8.51-6.97-9.90-7.48-6.92
Capital Expenditure ---0.09-0.16-0.64-0.23-0.35-0.67-0.15-0.27
Acquisitions and disposals -----0.58--1.50---
Investment purchases and sales ----------
Investing Cash Flow ----------
Insurance (repayment) of debt ----------
Insurance (buybacks) of shares ----------
Dividend payments ----------
Financing Cash Flow 2.552.266.582.1014.733.7815.027.846.115.88
Effect of forex changes on cash ----------
Net cash flow / Change in cash 0.08-0.202.73-2.025.64-4.975.92-2.83-1.52-1.30
Free Cash Flow -2.47-2.46-3.85-4.12-8.51-8.74-7.32-10.56-7.62-7.18
Net Cash/Marketcap -0.00-0.00-0.000.000.00-0.000.000.000.000.00

Retained Earning Schedule

Retained Earning Schedule

Year 2009201020112012201320142015201620172018
Retained Earnings (Previous Year) --143-151-162-169-187-200-212-224-237
Net Income 4-8-11-7-18-13-12-12-13-12
Stock Dividends -147---------
Divident Paid ----------
Retained Earnings -143-151-162-169-187-200-212-224-237-248

PPE Schedule

Year 2009201020112012201320142015201620172018
Gross PPE -000011111
Annual Depreciation 0-0001001-00
Capital Expenditure ---0-0-1-0-0-1-0-0
Net PPE 0000111110

Intangible and Goodwill Schedule

Intangible and Goodwill Schedule

Year 2009201020112012201320142015201620172018
Intangible and Goodwill (Previous Year) -110-00221
New Purchases ----------
Intangible and Goodwill 110-002211

Applied DNA Sciences Inc income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Applied DNA Sciences Inc FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.